Ironwood Pharmaceuticals, Inc. (FRA:I76)

Ironwood Pharmaceuticals Revenue

Ironwood Pharmaceuticals had revenue of $122.06M USD in the quarter ending September 30, 2025, with 33.26% growth. This brings the company's revenue in the last twelve months to $338.99M, down -10.42% year-over-year. In the year 2024, Ironwood Pharmaceuticals had annual revenue of $351.41M, down -20.63%.

• Revenue (ttm): $338.99M
• Revenue Growth: -10.42%
• P/S Ratio: 1.70
• Revenue / Employee: $1.34M
• Employees: 253
• Market Cap: 489.78M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	351.41M	-91.33M	-20.63%
Dec 31, 2023	442.74M	32.14M	7.83%
Dec 31, 2022	410.60M	-3.16M	-0.76%
Dec 31, 2021	413.75M	24.23M	6.22%
Dec 31, 2020	389.52M	-38.89M	-9.08%
Dec 31, 2019	428.41M	81.77M	23.59%
Dec 31, 2018	346.64M	48.36M	16.21%
Dec 31, 2017	298.28M	24.32M	8.88%
Dec 31, 2016	273.96M	124.40M	83.18%
Dec 31, 2015	149.56M	73.12M	95.66%
Dec 31, 2014	76.44M	53.56M	234.06%
Dec 31, 2013	22.88M	-127.36M	-84.77%
Dec 31, 2012	150.25M	84.37M	128.09%
Dec 31, 2011	65.87M	22.01M	50.19%
Dec 31, 2010	43.86M	9.54M	27.78%
Dec 31, 2009	34.32M	15.94M	86.70%
Dec 31, 2008	18.38M	7.92M	75.68%
Dec 31, 2007	10.46M	-	-